Skip to main content
Fig. 2 | Biomarker Research

Fig. 2

From: Integrative multi-omics analysis depicts the methylome and hydroxymethylome in recurrent bladder cancers and identifies biomarkers for predicting PD-L1 expression

Fig. 2

The rewiring 5mC and 5hmC landscape in recurrent bladder cancer. A The number of 5mC and 5hmC differentially methylated regions (DMRs) identified in recurrent bladder cancer samples (left). The genomic annotations of 5mC and 5hmC DMRs (right). B RNA-seq normalized count of fatty acid metabolism-related genes for 5hmC DMRs. C 5mC and 5hmC-specific qPCR for TUGB1 and EZHIP DMRs. D and E Correlation between differential methylation profiles in recurrent bladder cancer and five patients who developed recurrent UBC after tissue collection

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us